tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GILD Stock Latest News

Gilead Sciences Advances Ulcerative Colitis Treatment with GS-1427 Study
Company AnnouncementsGilead Sciences Advances Ulcerative Colitis Treatment with GS-1427 Study
12h ago
GILD
Gilead and Arcus Biosciences Complete Promising Cancer Study
PremiumCompany Announcements
Gilead and Arcus Biosciences Complete Promising Cancer Study
12h ago
GILD
Gilead announces EC authorization of Yeytuo for HIV prevention
PremiumThe Fly
Gilead announces EC authorization of Yeytuo for HIV prevention
3d ago
GILD
Gilead Sciences’ Promising Phase 3 Study in Lung Cancer Treatment
PremiumCompany Announcements
Gilead Sciences’ Promising Phase 3 Study in Lung Cancer Treatment
5d ago
GILD
Gilead Sciences Advances HIV-1 Treatment with New Clinical Study on GS-3242
PremiumCompany Announcements
Gilead Sciences Advances HIV-1 Treatment with New Clinical Study on GS-3242
5d ago
GILD
Gilead Sciences Advances Ulcerative Colitis Treatment with New Filgotinib Study
PremiumCompany AnnouncementsGilead Sciences Advances Ulcerative Colitis Treatment with New Filgotinib Study
5d ago
GILD
Gilead Sciences Advances in NSCLC Treatment: Key Study Update
Premium
Company Announcements
Gilead Sciences Advances in NSCLC Treatment: Key Study Update
5d ago
GILD
Gilead Sciences Advances Lung Cancer Treatment with New Clinical Study
Premium
Company Announcements
Gilead Sciences Advances Lung Cancer Treatment with New Clinical Study
7d ago
GILD
Gilead and Arcus Biosciences’ Promising Phase 3 Lung Cancer Study: Market Implications
PremiumCompany Announcements
Gilead and Arcus Biosciences’ Promising Phase 3 Lung Cancer Study: Market Implications
7d ago
GILD
RCUS
Gilead maximizing Yeztugo sales will likely require HHS action, says Leerink
PremiumThe Fly
Gilead maximizing Yeztugo sales will likely require HHS action, says Leerink
7d ago
CVS
GILD
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
7d ago
AMD
APM
Walmart reports mixed Q2, Thoma Bravo to acquire Dayforce: Morning Buzz
PremiumThe Fly
Walmart reports mixed Q2, Thoma Bravo to acquire Dayforce: Morning Buzz
8d ago
BA
BZ
Gilead Sciences’ New HIV Treatment Study: A Potential Game-Changer?
PremiumCompany AnnouncementsGilead Sciences’ New HIV Treatment Study: A Potential Game-Changer?
8d ago
GILD
Gilead Sciences Advances Ulcerative Colitis Treatment with Filgotinib Study
Premium
Company Announcements
Gilead Sciences Advances Ulcerative Colitis Treatment with Filgotinib Study
8d ago
GILD
CVS won’t add Gilead’s HIV shot to drug coverage lists, Reuters reports
Premium
The Fly
CVS won’t add Gilead’s HIV shot to drug coverage lists, Reuters reports
8d ago
CVS
GILD
Gilead to acquire Interius BioTherapeutics for $350M, sees dilution
PremiumThe Fly
Gilead to acquire Interius BioTherapeutics for $350M, sees dilution
8d ago
GILD
Gilead Sciences’ Promising Phase 3 Study in Lung Cancer Treatment
PremiumCompany Announcements
Gilead Sciences’ Promising Phase 3 Study in Lung Cancer Treatment
9d ago
GILD
Gilead Sciences: Strong Market Position and Investor Confidence Justify Buy Rating
PremiumRatings
Gilead Sciences: Strong Market Position and Investor Confidence Justify Buy Rating
9d ago
GILD
Gilead price target raised to $135 from $120 at Bernstein
PremiumThe Fly
Gilead price target raised to $135 from $120 at Bernstein
9d ago
GILD
Gilead upgraded to Outperform from Neutral at Daiwa
PremiumThe FlyGilead upgraded to Outperform from Neutral at Daiwa
10d ago
GILD
Gilead Sciences Appoints New Senior Vice President
Premium
Company Announcements
Gilead Sciences Appoints New Senior Vice President
14d ago
8K
GILD
Gilead Sciences’ Phase 3 Study on Triple Negative Breast Cancer: A Potential Game-Changer?
Premium
Company Announcements
Gilead Sciences’ Phase 3 Study on Triple Negative Breast Cancer: A Potential Game-Changer?
15d ago
GILD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >